Attached files
| file | filename |
|---|---|
| EX-31.2 - H-CYTE, INC. | ex31-2.htm |
| EX-31.1 - H-CYTE, INC. | ex31-1.htm |
| 10-Q - H-CYTE, INC. | form10-q.htm |
EXHIBIT 32.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND
CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13a-14(b) UNDER
THE SECURITIES EXCHANGE ACT OF 1934 AND SECTION 1350 OF
CHAPTER 63 OF TITLE 18 OF THE UNITED STATES CODE
Each of the undersigned, William E. Horne and Jeremy Daniel, certifies pursuant to Rule 13a-14(b) under the Securities Exchange Act of 1934 and Section 1350 of Chapter 63 of Title 18 of the United States Code, that (1) this quarterly report on Form 10-Q for the quarter ended March 31, 2020, of H-CYTE, Inc. (the “Company”) fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934, and (2) the information contained in this report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: May 21, 2020
| /s/ William E. Horne | |
| William E. Horne, | |
| Chief Executive Officer | |
| /s/ Jeremy Daniel | |
| Jeremy Daniel, | |
| Chief Financial Officer |